Interestingly, the plasma concentration achieved with once-weekly exenatide ER is comparable to that of a single injection of immediate-release exenatide (Byetta) [60, 61]
It is not FDA-approved for weight loss and is typically sold outside standard prescription channels as a compounded or research product
Effects of gastric inhibitory polypeptide on glucose and lipid metabolism of isolated rat adipocytes
Established supplements like berberine have decades of research
Meanwhile, Semaglutide GLP-1 (Ozempic, Wegovy) has shown promising results in terms of weight loss, despite its primary use for treating type 2 diabetes
For example, Wegovy prescribing information states that it is used with a reduced-calorie diet and increased physical activity to help certain adults and adolescents reduce excess body weight and maintain long-term weight reduction